XI’AN, China--(BUSINESS WIRE)--China Pharmaceuticals, Inc. (OTCBB: CFMID) (“China Pharmaceuticals, Inc.” or the “Company”), one of China’s leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals, today announced that it has effected a 5 for 6 reverse share split as of June 8, 2010.
